Financings In Brief: Geron
Executive Summary
Geron: Menlo Park, Calif. biopharmaceutical R&D firm files with the Securities & Exchange Commission for proposed initial public offering of 2.5 mil. common shares. Expected price per share is between $11 and $13. J.P. Morgan is lead underwriter, with Montgomery Securities and Salomon Brothers acting as co-managers...